A recent study published in the journal Expert Review of Neurotherapeutics highlights the long-term benefits of cannabis for patients with post-traumatic stress disorder (PTSD). Researchers from the United Kingdom evaluated the health-related quality of life (HRQoL) of 269 PTSD patients enrolled in the Medical Cannabis Registry. These patients used cannabis-based medicinal products (CBMPs) after conventional treatments failed.
The study assessed participants at intervals of 1, 3, 6, 12, and 18 months. Results indicated consistent improvements across all follow-up points in various areas, including PTSD symptoms, anxiety levels, sleep quality, and overall HRQoL. Importantly, these improvements were sustained throughout the 18-month study period.
Previous observational studies involving patients from the UK Medical Cannabis Registry have reported positive outcomes with cannabis for conditions such as cancer-related pain, anxiety, fibromyalgia, inflammatory bowel disease, and multiple sclerosis. These findings reinforce the potential of cannabis as a therapeutic alternative for various health issues.
In Arizona, where recreational cannabis use was legalized in November 2020, adults aged 21 and older can purchase and use cannabis. The state has seen over 150 dispensaries open, primarily in urban regions like Phoenix, Tucson, and Flagstaff, with recreational cannabis delivery services launching in 2024. The ongoing research into cannabis’s impact on health conditions remains crucial as more patients seek alternative treatments.
Czech 
English 
Spanish 
German